Advertisement
Research Article| Volume 63, ISSUE 2, P312-319, August 2015

Hepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity

  • Author Footnotes
    † These authors contributed equally to this work.
    Antonio Madejón
    Footnotes
    † These authors contributed equally to this work.
    Affiliations
    Hepatology Unit Hospital Universitario La Paz/Carlos III, Instituto de Investigación Sanitaria “La Paz”, Madrid, Spain

    Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Salud Carlos III, Madrid, Spain
    Search for articles by this author
  • Author Footnotes
    † These authors contributed equally to this work.
    Julie Sheldon
    Footnotes
    † These authors contributed equally to this work.
    Affiliations
    Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain
    Search for articles by this author
  • Irene Francisco-Recuero
    Affiliations
    Departamento de Bioquímica, UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain
    Search for articles by this author
  • Celia Perales
    Affiliations
    Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain

    Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Salud Carlos III, Madrid, Spain
    Search for articles by this author
  • Mariela Domínguez-Beato
    Affiliations
    Departamento de Bioquímica, UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain
    Search for articles by this author
  • Marina Lasa
    Affiliations
    Departamento de Bioquímica, UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain
    Search for articles by this author
  • Isabel Sánchez-Perez
    Affiliations
    Departamento de Bioquímica, UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain
    Search for articles by this author
  • Jordi Muntané
    Affiliations
    Oncology Surgery, Cell Therapy and Transplant Organs, Institute of Biomedicine of Seville (IBiS)-Virgen del Rocio Universitary Hospital (CSIC), University of Seville, Seville, Spain
    Search for articles by this author
  • Esteban Domingo
    Affiliations
    Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Consejo Superior de Investigaciones Científicas (CSIC), Campus de Cantoblanco, 28049 Madrid, Spain

    Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Salud Carlos III, Madrid, Spain
    Search for articles by this author
  • Javier García-Samaniego
    Affiliations
    Hepatology Unit Hospital Universitario La Paz/Carlos III, Instituto de Investigación Sanitaria “La Paz”, Madrid, Spain

    Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto Salud Carlos III, Madrid, Spain
    Search for articles by this author
  • Aurora Sánchez-Pacheco
    Correspondence
    Corresponding author. Address: Departamento de Bioquímica-Instituto de Investigaciones Biomédicas A. Sols (UAM-CSIC), Arturo Duperier 4, 28029 Madrid, Spain. Tel.: +34 15854418; fax: +34 15854401.
    Affiliations
    Departamento de Bioquímica, UAM, Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain
    Search for articles by this author
  • Author Footnotes
    † These authors contributed equally to this work.
Published:February 28, 2015DOI:https://doi.org/10.1016/j.jhep.2015.02.036

      Background & Aims

      Chronic hepatitis C is a leading cause of chronic liver disease, cirrhosis and hepatocellular carcinoma. DNA methylation and histone covalent modifications constitute crucial mechanisms of genomic instability in human disease, including liver fibrosis and hepatocellular carcinoma. The present work studies the consequences of HCV-induced histone modifications in early stages of infection.

      Methods

      Human primary hepatocytes and HuH7.5 cells were transiently transfected with the core protein of hepatitis C virus (HCV) genotypes 1a, 1b, and 2a. Infectious genotype 2a HCV in culture was also used.

      Results

      We show that HCV and core protein inhibit the phosphorylation of Serine 10 in histone 3. The inhibition is due to the direct interaction between HCV core and Aurora B kinase (AURKB) that results in a decrease of AURKB activity. HCV and core significantly downregulate NF-κB and COX-2 transcription, two proteins with anti-apoptotic and proliferative effects implicated in the control of the inflammatory response. AURKB depletion reduced HCV and core repression of NF-κB and COX-2 gene transcription and AURKB overexpression reversed the viral effect. AURKB abrogation increased HCV specific infectivity which was decreased when AURKB was overexpressed.

      Conclusions

      The core-mediated decrease of AURKB activity may play a role in the inflammatory pathway during the initial steps of viral infection, while ensuring HCV infectivity.

      Abbreviations:

      HCV (hepatitis C virus), HCC (hepatocellular carcinoma), AURKB (Aurora B kinase), PP2 (protein phosphatase 2), Chk1 (checkpoint kinase 1), NF-κB (nuclear factor-κB), COX-2 (cyclooxygenase-2)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ben-Neriah Y.
        • Karin M.
        Inflammation meets cancer, with NF-kappaB as the matchmaker.
        Nat Immunol. 2011; 12: 715-723
        • Bernsmeier C.
        • Duong F.H.
        • Christen V.
        • Pugnale P.
        • Negro F.
        • Terracciano L.
        • et al.
        Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
        J Hepatol. 2008; 49: 429-440
        • Blight K.J.
        • McKeating J.A.
        • Rice C.M.
        Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.
        J Virol. 2002; 76: 13001-13014
        • Chappell G.
        • Kutanzi K.
        • Uehara T.
        • Tryndyak V.
        • Hong H.H.
        • Hoenerhoff M.
        • et al.
        Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
        Int J Cancer. 2014; 134: 2778-2788
        • Chen C.
        • Pan D.
        • Deng A.M.
        • Huang F.
        • Sun B.L.
        • Yang R.G.
        DNA methyltransferases 1 and 3B are required for hepatitis C virus infection in cell culture.
        Virology. 2013; 441: 57-65
        • Chen H.S.
        • Lu F.
        • Lieberman P.M.
        Epigenetic regulation of EBV and KSHV latency.
        Curr Opin Virol. 2013; 3: 251-259
        • Donzelli M.
        • Draetta G.F.
        Regulating mammalian checkpoints through Cdc25 inactivation.
        EMBO Rep. 2003; 4: 671-677
        • Duong F.H.
        • Christen V.
        • Berke J.M.
        • Penna S.H.
        • Moradpour D.
        • Heim M.H.
        Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1.
        J Virol. 2005; 79: 15342-15350
        • Duong F.H.
        • Christen V.
        • Lin S.
        • Heim M.H.
        Hepatitis C virus-induced up-regulation of protein phosphatase 2A inhibits histone modification and DNA damage repair.
        Hepatology. 2010; 51: 741-751
        • Fang T.C.
        • Schaefer U.
        • Mecklenbrauker I.
        • Stienen A.
        • Dewell S.
        • Chen M.S.
        • et al.
        Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response.
        J Exp Med. 2012; 209: 661-669
        • Fu J.
        • Bian M.
        • Jiang Q.
        • Zhang C.
        Roles of Aurora kinases in mitosis and tumorigenesis.
        Mol Cancer Res. 2007; 5: 1-10
        • Giet R.
        • Petretti C.
        • Prigent C.
        Aurora kinases, aneuploidy and cancer, a coincidence or a real link?.
        Trends Cell Biol. 2005; 15: 241-250
        • Goto H.
        • Yasui Y.
        • Nigg E.A.
        • Inagaki M.
        Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation.
        Genes Cells. 2002; 7: 11-17
        • Hengeveld R.C.
        • Hertz N.T.
        • Vromans M.J.
        • Zhang C.
        • Burlingame A.L.
        • Shokat K.M.
        • et al.
        Development of a chemical genetic approach for human aurora B kinase identifies novel substrates of the chromosomal passenger complex.
        Mol Cell Proteomics. 2012; 11: 47-59
        • Jha H.C.
        • Lu J.
        • Saha A.
        • Cai Q.
        • Banerjee S.
        • Prasad M.A.
        • et al.
        EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
        J Virol. 2013; 87: 12121-12138
        • Jones C.T.
        • Catanese M.T.
        • Law L.M.
        • Khetani S.R.
        • Syder A.J.
        • Ploss A.
        • et al.
        Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system.
        Nat Biotechnol. 2010; 28: 167-171
        • Joo M.
        • Hahn Y.S.
        • Kwon M.
        • Sadikot R.T.
        • Blackwell T.S.
        • Christman J.W.
        Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta.
        J Virol. 2005; 79: 7648-7657
        • Kannan R.P.
        • Hensley L.L.
        • Evers L.E.
        • Lemon S.M.
        • McGivern D.R.
        Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis.
        J Virol. 2011; 85: 7989-8001
        • Katayama H.
        • Sen S.
        Aurora kinase inhibitors as anticancer molecules.
        Biochim Biophys Acta. 2010; 1799: 829-839
        • Lambert M.P.
        • Paliwal A.
        • Vaissiere T.
        • Chemin I.
        • Zoulim F.
        • Tommasino M.
        • et al.
        Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
        J Hepatol. 2011; 54: 705-715
        • Li Q.
        • Pene V.
        • Krishnamurthy S.
        • Cha H.
        • Liang T.J.
        Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly.
        Nat Med. 2013; 19: 722-729
        • Lin Z.Z.
        • Jeng Y.M.
        • Hu F.C.
        • Pan H.W.
        • Tsao H.W.
        • Lai P.L.
        • et al.
        Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
        BMC Cancer. 2010; 10: 461
        • Mann J.
        • Chu D.C.
        • Maxwell A.
        • Oakley F.
        • Zhu N.L.
        • Tsukamoto H.
        • et al.
        MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.
        Gastroenterology. 2010; 138 (714, e701–e704): 705-714
        • Mohamed M.R.
        • McFadden G.
        NFkB inhibitors: strategies from poxviruses.
        Cell Cycle. 2009; 8: 3125-3132
        • Moore P.S.
        • Chang Y.
        Why do viruses cause cancer? Highlights of the first century of human tumour virology.
        Nat Rev Cancer. 2010; 10: 878-889
        • Moriya K.
        • Fujie H.
        • Shintani Y.
        • Yotsuyanagi H.
        • Tsutsumi T.
        • Ishibashi K.
        • et al.
        The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
        Nat Med. 1998; 4: 1065-1067
        • Nguyen H.
        • Sankaran S.
        • Dandekar S.
        Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes.
        Virology. 2006; 354: 58-68
        • Nishida N.
        • Goel A.
        Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.
        Curr Genomics. 2011; 12: 130-137
        • Patel D.J.
        • Wang Z.
        Readout of epigenetic modifications.
        Annu Rev Biochem. 2013; 82: 81-118
        • Perales C.
        • Beach N.M.
        • Gallego I.
        • Soria M.E.
        • Quer J.
        • Esteban J.I.
        • et al.
        Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype.
        J Virol. 2013; 87: 7593-7607
        • Petsalaki E.
        • Akoumianaki T.
        • Black E.J.
        • Gillespie D.A.
        • Zachos G.
        Phosphorylation at serine 331 is required for Aurora B activation.
        J Cell Biol. 2011; 195: 449-466
        • Pichard L.
        • Raulet E.
        • Fabre G.
        • Ferrini J.B.
        • Ourlin J.C.
        • Maurel P.
        Human hepatocyte culture.
        Methods Mol Biol. 2006; 320: 283-293
        • Pietschmann T.
        • Kaul A.
        • Koutsoudakis G.
        • Shavinskaya A.
        • Kallis S.
        • Steinmann E.
        • et al.
        Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
        Proc Natl Acad Sci U S A. 2006; 103: 7408-7413
        • Rance E.
        • Tanner J.E.
        • Alfieri C.
        Inhibition of IkappaB kinase by thalidomide increases hepatitis C virus RNA replication.
        J Viral Hepat. 2012; 19: e73-80
        • Sabbattini P.
        • Canzonetta C.
        • Sjoberg M.
        • Nikic S.
        • Georgiou A.
        • Kemball-Cook G.
        • et al.
        A novel role for the Aurora B kinase in epigenetic marking of silent chromatin in differentiated postmitotic cells.
        EMBO J. 2007; 26: 4657-4669
        • Sawan C.
        • Vaissiere T.
        • Murr R.
        • Herceg Z.
        Epigenetic drivers and genetic passengers on the road to cancer.
        Mutat Res. 2008; 642: 1-13
        • Sugiyama K.
        • Sugiura K.
        • Hara T.
        • Sugimoto K.
        • Shima H.
        • Honda K.
        • et al.
        Aurora-B associated protein phosphatases as negative regulators of kinase activation.
        Oncogene. 2002; 21: 3103-3111
        • Tardaguila M.
        • Gonzalez-Gugel E.
        • Sanchez-Pacheco A.
        Aurora kinase B activity is modulated by thyroid hormone during transcriptional activation of pituitary genes.
        Mol Endocrinol. 2011; 25: 385-393
        • Wang Y.
        • Xu Y.
        • Tong W.
        • Pan T.
        • Li J.
        • Sun S.
        • et al.
        Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP).
        J Biol Chem. 2011; 286: 26603-26615
        • Yasui Y.
        • Urano T.
        • Kawajiri A.
        • Nagata K.
        • Tatsuka M.
        • Saya H.
        • et al.
        Autophosphorylation of a newly identified site of Aurora-B is indispensable for cytokinesis.
        J Biol Chem. 2004; 279: 12997-13003
        • Zachos G.
        • Black E.J.
        • Walker M.
        • Scott M.T.
        • Vagnarelli P.
        • Earnshaw W.C.
        • et al.
        Chk1 is required for spindle checkpoint function.
        Dev Cell. 2007; 12: 247-260